dalteparin
Generic: DALTEPARIN SODIUM·Brand: FRAGMIN
dalteparin: 1 clinical trial tracked.
dalteparin evidence translation
What we can confirm
1 tracked trial
No verified listed developer
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about dalteparin, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 1 study sponsors
Related indications
Study sponsors
Clinical Trials (1)
A Multicenter, Randomized, Open-label, Blinded Endpoint Evaluation, Phase 3 Study Comparing the Effect of Abelacimab vs. Dalteparin on Venous Thromboembolism (VTE) Recurrence and Bleeding in Patients With GI/GU Associated VTE
Primary endpoint: Time to first event of centrally adjudicated VTE recurrence
InterventionalRandomizedsingle417 targetStarted 2022-09Completion 2026-0450 sites · Australia, Austria, Canada, China…Anthos Therapeutics, Inc.